Stockreport

Immunic, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update [Yahoo! Finance]

Immunic, Inc.  (IMUX) 
PDF company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced that the compan [Read more]